Arkstone, a pioneer in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical decision support and antimicrobial stewardship, has announced being acquired by ARCHIMED, a leading private equity firm specializing in the healthcare sector. The transaction marks a pivotal moment in Arkstone’s growth trajectory, positioning the company to expand its global footprint, deepen its R&D capabilities, and bring its precision-guided technology to more clinicians around the world. Backed by ARCHIMED’s capital, extensive healthcare expertise, and international reach, Arkstone is poised to scale its impact on the global fight against antimicrobial resistance (AMR), one of the most urgent public health threats of our time.
Read the full article: ARCHIMED Acquires a Majority Stake in Arkstone, Forging a Powerful Partnership to Accelerate Global Healthcare Innovation and Dominate the Emerging AI-Driven Clinical Decision Support Market //
Source: https://www.prnewswire.com/news-releases/archimed-acquires-a-majority-stake-in-arkstone-forging-a-powerful-partnership-to-accelerate-global-healthcare-innovation-and-dominate-the-emerging-ai-driven-clinical-decision-support-market-302517683.html